Mark Coleman - 19 Nov 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
19 Nov 2024
Net transactions value
+$198,455
Form type
4
Filing time
20 Nov 2024, 16:30:41 UTC
Previous filing
11 Jun 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $198,455 +33,410 +229% $5.94 48,010 19 Nov 2024 Direct F1
holding AXSM Common Stock 403,856 19 Nov 2024 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -33,410 -100% $0.000000 0 19 Nov 2024 Common Stock 33,410 $5.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise of stock options prior to expiration for cash and hold of underlying shares.
F2 Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.